文献速递糖尿病

趾臂指数作为2型糖尿病合并微量白蛋白尿患者心血管疾病及全因死亡的预测指标

Toe-brachial index as a predictor of cardiovascular disease and all-cause mortality in people with type 2 diabetes and microalbuminuria.
PubMed 文献 · Diabetologia · 2017-07-05

这项前瞻性研究纳入200例2型糖尿病合并微量白蛋白尿患者,评估趾臂指数(TBI)与踝臂指数(ABI)对心血管疾病(CVD)及全因死亡的预测价值。中位随访6.1年,记录40例CVD事件和26例死亡。TBI和ABI降低均与CVD及全因死亡风险升高相关,独立于传统危险因素,并改善预后准确性。

要点

  • TBI每降低1个标准差,CVD风险HR为1.55,全因死亡HR为1.41(未校正)。
  • 校正传统危险因素后,TBI仍为CVD的独立决定因素(HR 1.50)。
  • TBI加入传统危险因素后CVD的AUC显著提高0.063(95%CI 0.012,0.115)。

核心结论

  • TBI和ABI降低与2型糖尿病合并微量白蛋白尿患者CVD及全因死亡风险升高相关,独立于传统危险因素,并改善预后准确性。

研究设计与样本

  • 前瞻性研究,纳入200例2型糖尿病合并微量白蛋白尿患者,采用未校正和校正(传统危险因素及额外纳入NT-proBNP和冠状动脉钙化)的Cox回归模型。

主要发现

  • 中位随访6.1年,记录40例CVD事件和26例死亡。
  • 未校正时,TBI每降低1个标准差,CVD的HR为1.55(95%CI 1.38,1.68),全因死亡的HR为1.41(95%CI 1.22,1.60)。
  • 校正传统危险因素后,TBI每降低1个标准差,CVD的HR为1.50(95%CI 1.27,1.65),全因死亡的HR为1.37(95%CI 1.01,1.60)。
  • 未校正时,ABI每降低1个标准差,CVD的HR为1.49(95%CI 1.32,1.61),全因死亡的HR为1.37(95%CI 1.09,1.57);校正传统危险因素后,CVD的HR为1.44(95%CI 1.23,1.59),全因死亡的HR为1.39(95%CI 1.07,1.60)。
  • 额外校正NT-proBNP和冠状动脉钙化后,TBI降低仍为CVD的决定因素(p=0.023)。

关键数值与推荐

  • TBI加入传统危险因素后,CVD的AUC从0.743显著提高0.063(95%CI 0.012,0.115)(p=0.016),全因死亡的AUC未显著改善;加入ABI未显著改善AUC。
  • TBI的rIDI对CVD为46.7%(p<0.001),对全因死亡为46.0%(p=0.002);ABI的rIDI对CVD为51.8%(p=0.004),对全因死亡为53.6%(p=0.031)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: The study aimed to evaluate toe-brachial index (TBI) and ankle-brachial index (ABI) as determinants of incident cardiovascular disease (CVD) and all-cause mortality in people with type 2 diabetes and microalbuminuria. METHODS: This was a prospective study including 200 participants. Unadjusted and adjusted (traditional risk factors and additional inclusion of N-terminal pro-brain natriuretic peptide [NT-proBNP] and coronary artery calcification) Cox regression models were performed. C statistics and relative integrated discrimination improvement (rIDI) evaluated risk prediction improvement. RESULTS: Median follow-up was 6.1 years; 40 CVD events and 26 deaths were recorded. Lower TBI was associated with increased risk of CVD (HR per 1 SD decrease: 1.55 [95% CI 1.38, 1.68]) and all-cause mortality (1.41 [1.22, 1.60]) unadjusted and after adjustment for traditional risk factors (CVD 1.50 [1.27, 1.65] and all-cause mortality 1.37 [1.01, 1.60]). Lower ABI was a determinant of CVD (1.49 [1.32, 1.61]) and all-cause mortality (1.37 [1.09, 1.57]) unadjusted and after adjustment for traditional risk factors (CVD 1.44 [1.23, 1.59] and all-cause mortality 1.39 [1.07, 1.60]). After additional adjustment for NT-proBNP and coronary artery calcification, lower TBI remained a determinant of CVD (p = 0.023). When TBI was added to traditional risk factors, the AUC increased significantly for CVD, by 0.063 (95% CI 0.012, 0.115) from 0.743 (p = 0.016), but not for all-cause mortality; adding ABI did not improve the AUC significantly. The rIDI for TBI was 46.7% (p < 0.001) for CVD and 46.0% (p = 0.002) for all-cause mortality; for ABI, the rIDI was 51.8% (p = 0.004) for CVD and 53.6% (p = 0.031) for all-cause mortality. CONCLUSIONS/INTERPRETATION: Reduced TBI and ABI were associated with increased risk of CVD and all-cause mortality, independent of traditional risk factors in type 2 diabetes, and improved prognostic accuracy.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Zobel EH, von Scholten BJ, Reinhard H, et al. Toe-brachial index as a predictor of cardiovascular disease and all-cause mortality in people with type 2 diabetes and microalbuminuria. Diabetologia. 2017. PMID: 28681124. doi:10.1007/s00125-017-4344-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。